• BanRep is expected to accelerate its hiking cycle


BanRep will hold the fourth monetary policy meeting of the year on Thursday, June 30. In April’s meeting, the vote was split between four Board members voting for a 100 bps hike and three members who voted for a 150 bps hike. New information since that meeting could skew the decision to the hawkish side as private consumption remains strong, core inflation reached its highest level since 2003, and inflation expectations remain above the central bank target even over a two-year window. We expect the central bank to accelerate the pace of hiking and increase the policy rate by 150 bps to 7.50%.

Key points to have in mind ahead of Thursday’s BanRep vote:

  • In April’s meeting, the hawks on the Board argued that inflation expectations increased and were pointing to a persistent price shock. They also highlighted that credit, especially for consumption, was increasing at a strong pace. While the majority group, who voted for a 100 bps hike, expressed some concerns about a potential deceleration in economic activity, they argued in support of a gradual approach.
  • Since April’s meeting, incoming information showed robust economic activity. GDP growth was 8.5% in Q1-2022, while in the YTD to April it was 9.3%. Consumption remains strong despite the inflationary environment and some indicators such as consumer credit growth which is above the 20% y/y, and demand, boosted by the VAT holiday, could justify more aggressive monetary policy.
  • Despite an easing of May headline inflation, core inflation reached the highest level since 2003 at 6.5% because of high indexation effects and price increases in services due to the strong demand amid the total reopening. 
  • An additional risk is the possibility of a surge in inflation owing to the potential increase in gasoline prices announced by the government. For each additional 200 pesos in gasoline prices, inflation could increase by 0.6 ppts, which would move year-end inflation expectations above the 10%, again triggering significant indexation effects in 2023.
  • Inflation expectations have increased and by the end of 2022 inflation is expected to close at 8.78%. Meanwhile, two-year ahead inflation expectations are above the ceiling of the target range (defined between 2% and 4%). 
  • International conditions point to tighter financial conditions down the road. In recent weeks the Federal Reserve has turned more hawkish, increasing its monetary policy rates by 75 bps, the strongest pace since 1994. The Fed also signaled that its terminal rate would be around 4%, which is an important consideration for the BanRep Board, and could motivate an acceleration in the hiking cycle.
  • The political environment could trigger a higher risk premium in Colombia. The USDCOP reached a historical high and international turbulence would make consider the Board to speed up the hiking cycle.
  • Finally, any signal from BanRep that it is close to the end of its hiking cycle is key since market and Scotiabank Economics expectations point to a terminal rate of 8.50%.

All in all, ahead of June’s meeting our base case scenario is a 150 bps hike, with a split vote. The vote and communications around it will be key to assessing future steps in the hiking cycle. Inflation developments in the coming months will determine the terminal rate; for now, we expect the current tightening cycle to end at 8.5% with the policy rate remaining at this level for around twelve months. However, if inflation increases more than anticipated, the policy rate would clearly go even higher.


This report has been prepared by Scotiabank Economics as a resource for the clients of Scotiabank. Opinions, estimates and projections contained herein are our own as of the date hereof and are subject to change without notice. The information and opinions contained herein have been compiled or arrived at from sources believed reliable but no representation or warranty, express or implied, is made as to their accuracy or completeness. Neither Scotiabank nor any of its officers, directors, partners, employees or affiliates accepts any liability whatsoever for any direct or consequential loss arising from any use of this report or its contents.

These reports are provided to you for informational purposes only. This report is not, and is not constructed as, an offer to sell or solicitation of any offer to buy any financial instrument, nor shall this report be construed as an opinion as to whether you should enter into any swap or trading strategy involving a swap or any other transaction. The information contained in this report is not intended to be, and does not constitute, a recommendation of a swap or trading strategy involving a swap within the meaning of U.S. Commodity Futures Trading Commission Regulation 23.434 and Appendix A thereto. This material is not intended to be individually tailored to your needs or characteristics and should not be viewed as a “call to action” or suggestion that you enter into a swap or trading strategy involving a swap or any other transaction. Scotiabank may engage in transactions in a manner inconsistent with the views discussed this report and may have positions, or be in the process of acquiring or disposing of positions, referred to in this report.

Scotiabank, its affiliates and any of their respective officers, directors and employees may from time to time take positions in currencies, act as managers, co-managers or underwriters of a public offering or act as principals or agents, deal in, own or act as market makers or advisors, brokers or commercial and/or investment bankers in relation to securities or related derivatives. As a result of these actions, Scotiabank may receive remuneration. All Scotiabank products and services are subject to the terms of applicable agreements and local regulations. Officers, directors and employees of Scotiabank and its affiliates may serve as directors of corporations.

Any securities discussed in this report may not be suitable for all investors. Scotiabank recommends that investors independently evaluate any issuer and security discussed in this report, and consult with any advisors they deem necessary prior to making any investment.

This report and all information, opinions and conclusions contained in it are protected by copyright. This information may not be reproduced without the prior express written consent of Scotiabank.

™ Trademark of The Bank of Nova Scotia. Used under license, where applicable.

Scotiabank, together with “Global Banking and Markets”, is a marketing name for the global corporate and investment banking and capital markets businesses of The Bank of Nova Scotia and certain of its affiliates in the countries where they operate, including; Scotiabank Europe plc; Scotiabank (Ireland) Designated Activity Company; Scotiabank Inverlat S.A., Institución de Banca Múltiple, Grupo Financiero Scotiabank Inverlat, Scotia Inverlat Casa de Bolsa, S.A. de C.V., Grupo Financiero Scotiabank Inverlat, Scotia Inverlat Derivados S.A. de C.V. – all members of the Scotiabank group and authorized users of the Scotiabank mark. The Bank of Nova Scotia is incorporated in Canada with limited liability and is authorised and regulated by the Office of the Superintendent of Financial Institutions Canada. The Bank of Nova Scotia is authorized by the UK Prudential Regulation Authority and is subject to regulation by the UK Financial Conduct Authority and limited regulation by the UK Prudential Regulation Authority. Details about the extent of The Bank of Nova Scotia's regulation by the UK Prudential Regulation Authority are available from us on request. Scotiabank Europe plc is authorized by the UK Prudential Regulation Authority and regulated by the UK Financial Conduct Authority and the UK Prudential Regulation Authority.

Scotiabank Inverlat, S.A., Scotia Inverlat Casa de Bolsa, S.A. de C.V, Grupo Financiero Scotiabank Inverlat, and Scotia Inverlat Derivados, S.A. de C.V., are each authorized and regulated by the Mexican financial authorities.

Not all products and services are offered in all jurisdictions. Services described are available in jurisdictions where permitted by law.